Common Shares Outstanding: The number of class A shares currently held by investors.
Tyra Biosciences, Inc. (TYRA) had Common Shares Outstanding of 43.02M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-69.13M |
|
-- |
|
-- |
|
$79.94M |
|
$-79.94M |
|
$10.81M |
|
$-69.13M |
|
$-69.13M |
|
$-69.13M |
|
$-69.13M |
|
$-69.13M |
|
$-69.13M |
|
$-79.94M |
|
$-79.59M |
|
42.70M |
|
42.70M |
|
$-1.62 |
|
$-1.62 |
|
| Balance Sheet Financials | |
$211.67M |
|
$1.63M |
|
$14.19M |
|
$225.86M |
|
$15.33M |
|
-- |
|
$6.26M |
|
$21.59M |
|
$204.26M |
|
$204.26M |
|
$204.26M |
|
|
Common Shares Outstanding |
43.02M |
| Cash Flow Statement Financials | |
$-50.14M |
|
$-144.60M |
|
$1.54M |
|
$252.21M |
|
$59.01M |
|
$-193.21M |
|
$13.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-50.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.85% |
|
-33.85% |
|
-30.61% |
|
-33.85% |
|
$4.75 |
|
$-1.19 |
|
$-1.17 |
|